Balancing immunity and tolerance: Genetic footprint of natural selection in the transcriptional regulatory region of HLA-G

Genes and Immunity

Volumn 16, Issue 1, 2015, Pages 57-70

  Gineau, L ^a,b   Luisi, P ^c   Castelli, E C ^d   Milet, J ^e   Courtin, D ^e   Cagnin, N ^f   Patillon, B ^a,b,g   Laayouni, H ^c   Moreau, P ^h,i   Donadi, E A ^f   Garcia, A ^a,b   Sabbagh, A ^a,b  

^a INSTITUT DE RECHERCHE POUR LE DÉVELOPPEMENT   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c UNIVERSITAT POMPEU FABRA   (Spain)

^d SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^e UNIVERSITY OF ABOMEY CALAVI   (Benin)

^f UNIVERSITY OF SÃO PAULO   (Brazil)

^g UNIVERSITÉ PARIS SACLAY   (France)

^h Inst Univ d'Hématologie   (France)

ⁱ UNIVERSITÉ PARIS DIDEROT   (France)

Author keywords

[No Author keywords available]

Indexed keywords

HLA G ANTIGEN;

5' UPSTREAM REGULATORY REGION; ARTICLE; BENIN; CONGO; CONTROLLED STUDY; GENE EXPRESSION; GENE LINKAGE DISEQUILIBRIUM; GENE LOCUS; GENE STRUCTURE; GENEALOGY; GENETIC VARIABILITY; HAPLOTYPE; HUMAN; IMMUNITY; IMMUNOLOGICAL TOLERANCE; NATURAL SELECTION; NUCLEOTIDE SEQUENCE; POPULATION DIFFERENTIATION; POPULATION GENETICS; PRIORITY JOURNAL; SENEGAL; TRANSCRIPTION REGULATION; GENETIC POLYMORPHISM; GENETIC SELECTION; GENETICS; IMMUNOLOGY; REGULATORY SEQUENCE;

GENETICS, POPULATION; HAPLOTYPES; HLA-G ANTIGENS; HUMANS; IMMUNE TOLERANCE; LINKAGE DISEQUILIBRIUM; POLYMORPHISM, GENETIC; REGULATORY ELEMENTS, TRANSCRIPTIONAL; SELECTION, GENETIC;

EID: 84921539940     PISSN: 14664879     EISSN: 14765470     Source Type: Journal    
DOI: 10.1038/gene.2014.63     Document Type: Article

References (86)

1. Rouas-Freiss N, Goncalves RM, Menier C, Dausset J, Carosella ED. Direct evidence to support the role of HLA-G in protecting the fetus from maternal uterine natural killer cytolysis. Proc Natl Acad Sci USA 1997; 94: 11520-11525.
2. Le Gal FA, Riteau B, Sedlik C, Khalil-Daher I, Menier C, Dausset J et al. HLA-Gmediated inhibition of antigen-specific cytotoxic T lymphocytes. Int Immunol 1999; 11: 1351-1356.
3. Ristich V, Liang S, Zhang W, Wu J, Horuzsko A. Tolerization of dendritic cells by HLA-G. Eur J Immunol 2005; 35: 1133-1142.
4. Berger DS, Hogge WA, Barmada MM, Ferrell RE. Comprehensive analysis of HLA-G: implications for recurrent spontaneous abortion. Reprod Sci 2010; 17: 331-338.
5. Naji A, Menier C, Morandi F, Agaugue S, Maki G, Ferretti E et al. Binding of HLA-G to ITIM-bearing Ig-like transcript 2 receptor suppresses B cell responses. J Immunol 2014; 192: 1536-1546.
6. Larsen MH, Hviid TV. Human leukocyte antigen-G polymorphism in relation to expression, function, and disease. Hum Immunol 2009; 70: 1026-1034.
7. Donadi EA, Castelli EC, Arnaiz-Villena A, Roger M, Rey D, Moreau P. Implications of the polymorphism of HLA-G on its function, regulation, evolution and disease association. Cell Mol Life Sci 2011; 68: 369-395.
8. Gonzalez A, Rebmann V, LeMaoult J, Horn PA, Carosella ED, Alegre E. The immunosuppressive molecule HLA-G and its clinical implications. Crit Rev Clin Lab Sci 2012; 49: 63-84.
9. Tan Z, Shon AM, Ober C. Evidence of balancing selection at the HLA-G promoter region. Hum Mol Genet 2005; 14: 3619-3628.
10. Alvarez M, Piedade J, Balseiro S, Ribas G, Regateiro F. HLA-G 3'-UTR SNP and 14-bp deletion polymorphisms in Portuguese and Guinea-Bissau populations. Int J Immunogenet 2009; 36: 361-366.
11. Castelli EC, Mendes-Junior CT, Deghaide NH, de Albuquerque RS, Muniz YC, Simoes RT et al. The genetic structure of 3'untranslated region of the HLA-G gene: polymorphisms and haplotypes. Genes Immun 2010; 11: 134-141.
12. Castelli EC, Mendes-Junior CT, Veiga-Castelli LC, Roger M, Moreau P, Donadi EA. A comprehensive study of polymorphic sites along the HLA-G gene: implication for gene regulation and evolution. Mol Biol Evol 2011; 28: 3069-3086.
13. Lucena-Silva N, Monteiro AR, de Albuquerque RS, Gomes RG, Mendes-Junior CT, Castelli EC et al. Haplotype frequencies based on eight polymorphic sites at the 3' untranslated region of the HLA-G gene in individuals from two different geographical regions of Brazil. Tissue Antigens 2012; 79: 272-278.
14. Sabbagh A, Luisi P, Castelli EC, Gineau L, Courtin D, Milet J et al. Worldwide genetic variation at the 3' untranslated region of the HLA-G gene: balancing selection influencing genetic diversity. Genes Immun 2014; 15: 95-106.
15. Tan Z, Randall G, Fan J, Camoretti-Mercado B, Brockman-Schneider R, Pan L et al. Allele-specific targeting of microRNAs to HLA-G and risk of asthma. Am J Hum Genet 2007; 81: 829-834.
16. Yie SM, Li LH, Xiao R, Librach CL. A single base-pair mutation in the 3'-untranslated region of HLA-G mRNA is associated with pre-eclampsia. Mol Hum Reprod 2008; 14: 649-653.
17. Castelli EC, Moreau P, Oya e Chiromatzo A, Mendes-Junior CT, Veiga-Castelli LC, Yaghi L et al. In silico analysis of microRNAS targeting the HLA-G 3' untranslated region alleles and haplotypes. Hum Immunol 2009; 70: 1020-1025.
18. Ober C, Aldrich CL, Chervoneva I, Billstrand C, Rahimov F, Gray HL et al. Variation in the HLA-G promoter region influences miscarriage rates. Am J Hum Genet 2003; 72: 1425-1435.
19. Costa CH, Gelmini GF, Wowk PF, Mattar SB, Vargas RG, Roxo VM et al. HLA-G regulatory haplotypes and implantation outcome in couples who underwent assisted reproduction treatment. Hum Immunol 2012; 73: 891-897.
20. Martinez-Laso J, Herraiz MA, Penaloza J, Barbolla ML, Jurado ML, Macedo J et al. Promoter sequences confirm the three different evolutionary lineages described for HLA-G. Hum Immunol 2013; 74: 383-388.
21. Castelli EC, Ramalho J, Porto I, Lima TH, Felicio LP, Sabbagh A et al. Insights into HLA-G genetics provided by worldwide haplotype diversity. Front Immunol 2014; 5: 476.
22. Nicolae D, Cox NJ, Lester LA, Schneider D, Tan Z, Billstrand C et al. Fine mapping and positional candidate studies identify HLA-G as an asthma susceptibility gene on chromosome 6p21. Am J Hum Genet 2005; 76: 349-357.
23. Doherty VL, Rush AN, Brennecke SP, Moses EK. The-56T HLA-G promoter polymorphism is not associated with pre-eclampsia/eclampsia in Australian and New Zealand women. Hypertens Pregnancy 2006; 25: 63-71.
24. Ober C, Billstrand C, Kuldanek S, Tan Z. The miscarriage-associated HLA-G-725G allele influences transcription rates in JEG-3 cells. Hum Reprod 2006; 21: 1743-1748.
25. Kroner A, Grimm A, Johannssen K, Maurer M, Wiendl H. The genetic influence of the nonclassical MHC molecule HLA-G on multiple sclerosis. Hum Immunol 2007; 68: 422-425.
26. Kim SK, Hong MS, Shin MK, Uhm YK, Chung JH, Lee MH. Promoter polymorphisms of the HLA-G gene, but not the HLA-E and HLA-F genes, is associated with non-segmental vitiligo patients in the Korean population. Arch Dermatol Res 2011; 303: 679-684.
27. Kim SK, Chung JH, Kim DH, Yun DH, Hong SJ, Lee KH. Lack of association between promoter polymorphisms of HLA-G gene and rheumatoid arthritis in Korean population. Rheumatol Int 2012; 32: 509-512.
28. Misra MK, Prakash S, Kapoor R, Pandey SK, Sharma RK, Agrawal S. Association of HLA-G promoter and 14-bp insertion-deletion variants with acute allograft rejection and end-stage renal disease. Tissue Antigens 2013; 82: 317-326.
29. Castelli EC, Veiga-Castelli LC, Yaghi L, Moreau P. Transcriptional and posttranscriptional regulations of the HLA-G gene. J Immunol Res 2014; 2014: 734068.
30. Schmidt CM, Ehlenfeldt RG, Athanasiou MC, Duvick LA, Heinrichs H, David CS et al. Extraembryonic expression of the human MHC class I gene HLA-G in transgenic mice. Evidence for a positive regulatory region located 1 kilobase 5' to the start site of transcription. J Immunol 1993; 151: 2633-2645.
31. Moreau P, Paul P, Gourand L, Prost S, Dausset J, Carosella E et al. HLA-G gene transcriptional regulation in trophoblasts and blood cells: differential binding of nuclear factors to a regulatory element located 1.1 kb from exon 1. Hum Immunol 1997; 52: 41-46.
32. Abecasis GR, Auton A, Brooks LD, DePristo MA, Durbin RM, Handsaker RE et al. An integrated map of genetic variation from 1,092 human genomes. Nature 2012; 491: 56-65.
33. Stephens M, Donnelly P. A comparison of bayesian methods for haplotype reconstruction from population genotype data. Am J Hum Genet 2003; 73: 1162-1169.
34. Wright S. The genetical structure of populations. Ann Eugen 1951; 15: 323-354.
35. Akey JM, Zhang G, Zhang K, Jin L, Shriver MD. Interrogating a high-density SNP map for signatures of natural selection. Genome Res 2002; 12: 1805-1814.
36. Elhaik E. Empirical distributions of F(ST) from large-scale human polymorphism data. PLoS ONE 2012; 7: e49837.
37. Mu XJ, Lu ZJ, Kong Y, Lam HY, Gerstein MB. Analysis of genomic variation in noncoding elements using population-scale sequencing data from the 1000 Genomes Project. Nucleic Acids Res 2011; 39: 7058-7076.
38. Prado-Martinez J, Sudmant PH, Kidd JM, Li H, Kelley JL, Lorente-Galdos B et al. Great ape genetic diversity and population history. Nature 2013; 499: 471-475.
39. Solier C, Mallet V, Lenfant F, Bertrand A, Huchenq A, Le Bouteiller P. HLA-G unique promoter region: functional implications. Immunogenetics 2001; 53: 617-625.
40. Kovats S, Main EK, Librach C, Stubblebine M, Fisher SJ, DeMars R. A class I antigen, HLA-G, expressed in human trophoblasts. Science 1990; 248: 220-223.
41. Crisa L, McMaster MT, Ishii JK, Fisher SJ, Salomon DR. Identification of a thymic epithelial cell subset sharing expression of the class Ib HLA-G molecule with fetal trophoblasts. J Exp Med 1997; 186: 289-298.
42. Moreau P, Flajollet S, Carosella ED. Non-classical transcriptional regulation of HLAG: an update. J Cell Mol Med 2009; 13: 2973-2989.
43. Gobin SJ, Peijnenburg A, Keijsers V, van den Elsen PJ. Site alpha is crucial for two routes of IFN gamma-induced MHC class I transactivation: the ISRE-mediated route and a novel pathway involving CIITA. Immunity 1997; 6: 601-611.
44. Gobin SJ, Keijsers V, van Zutphen M, van den Elsen PJ. The role of enhancer A in the locus-specific transactivation of classical and nonclassical HLA class I genes by nuclear factor kappa B. J Immunol 1998; 161: 2276-2283.
45. Gobin SJ, van Zutphen M, Woltman AM, van den Elsen PJ. Transactivation of classical and nonclassical HLA class I genes through the IFN-stimulated response element. J Immunol 1999; 163: 1428-1434.
46. Ibrahim EC, Morange M, Dausset J, Carosella ED, Paul P. Heat shock and arsenite induce expression of the nonclassical class I histocompatibility HLA-G gene in tumor cell lines. Cell Stress Chaperones 2000; 5: 207-218.
47. Lefebvre S, Berrih-Aknin S, Adrian F, Moreau P, Poea S, Gourand L et al. A specific interferon (IFN)-stimulated response element of the distal HLA-G promoter binds IFN-regulatory factor 1 and mediates enhancement of this nonclassical class I gene by IFN-beta. J Biol Chem 2001; 276: 6133-6139.
48. Schmidt CM, Chen HL, Chiu I, Ehlenfeldt RG, Hunt JS, Orr HT. Temporal and spatial expression of HLA-G messenger RNA in extraembryonic tissues of transgenic mice. J Immunol 1995; 155: 619-629.
49. Campbell MC, Tishkoff SA. African genetic diversity: implications for human demographic history, modern human origins, and complex disease mapping. Annu Rev Genomics Hum Genet 2008; 9: 403-433.
50. Bamshad M, Wooding SP. Signatures of natural selection in the human genome. Nat Rev Genet 2003; 4: 99-111.
51. Nielsen R, Hellmann I, Hubisz M, Bustamante C, Clark AG. Recent and ongoing selection in the human genome. Nat Rev Genet 2007; 8: 857-868.
52. Single RM, Martin MP, Gao X, Meyer D, Yeager M, Kidd JR et al. Global diversity and evidence for coevolution of KIR and HLA. Nat Genet 2007; 39: 1114-1119.
53. Li Q, Peterson KR, Fang X, Stamatoyannopoulos G. Locus control regions. Blood 2002; 100: 3077-3086.
54. Deschaseaux F, Gaillard J, Langonne A, Chauveau C, Naji A, Bouacida A et al. Regulation and function of immunosuppressive molecule human leukocyte antigen G5 in human bone tissue. Faseb J 2013; 27: 2977-2987.
55. Martelli-Palomino G, Pancotto JA, Muniz YC, Mendes-Junior CT, Castelli EC, Massaro JD et al. Polymorphic sites at the 3' untranslated region of the HLA-G gene are associated with differential hla-g soluble levels in the Brazilian and French population. PLoS ONE 2013; 8: e71742.
56. Hiby SE, King A, Sharkey A, Loke YW. Molecular studies of trophoblast HLA-G: polymorphism, isoforms, imprinting and expression in preimplantation embryo. Tissue Antigens 1999; 53: 1-13.
57. O'Brien M, McCarthy T, Jenkins D, Paul P, Dausset J, Carosella ED et al. Altered HLA-G transcription in pre-eclampsia is associated with allele specific inheritance: possible role of the HLA-G gene in susceptibility to the disease. Cell Mol Life Sci 2001; 58: 1943-1949.
58. Rebmann V, van der Ven K, Passler M, Pfeiffer K, Krebs D, Grosse-Wilde H. Association of soluble HLA-G plasma levels with HLA-G alleles. Tissue Antigens 2001; 57: 15-21.
59. Hviid TV, Hylenius S, Rorbye C, Nielsen LG. HLA-G allelic variants are associated with differences in the HLA-G mRNA isoform profile and HLA-G mRNA levels. Immunogenetics 2003; 55: 63-79.
60. Rousseau P, Le Discorde M, Mouillot G, Marcou C, Carosella ED, Moreau P. The 14 bp deletion-insertion polymorphism in the 3' UT region of the HLA-G gene influences HLA-G mRNA stability. Hum Immunol 2003; 64: 1005-1010.
61. Svendsen SG, Hantash BM, Zhao L, Faber C, Bzorek M, Nissen MH et al. The expression and functional activity of membrane-bound human leukocyte antigen-G1 are influenced by the 3'-untranslated region. Hum Immunol 2013; 74: 818-827.
62. Castelli EC, Mendes-Junior CT, Donadi EA. HLA-G alleles and HLA-G 14 bp polymorphisms in a Brazilian population. Tissue Antigens 2007; 70: 62-68.
63. Mendes-Junior CT, Castelli EC, Meyer D, Simoes AL, Donadi EA. Genetic diversity of the HLA-G coding region in Amerindian populations from the Brazilian Amazon: a possible role of natural selection. Genes Immun 2013; 14: 518-526.
64. Santos KE, Lima TH, Felicio LP, Massaro JDPalomino GM, Silva AC et al. Insights on the HLA-G evolutionary history provided by a nearby Alu insertion. Mol Biol Evol 2013; 30: 2423-2424.
65. Julie DC, Buhler S, Frassati C, Basire A, Galicher V, Baier C et al. Linkage disequilibrium between HLA-G∗0104 and HLA-E∗0103 alleles in Tswa Pygmies. Tissue Antigens 2011; 77: 193-200.
66. Courtin D, Milet J, Jamonneau V, Yeminanga CS, Kumeso VK, Bilengue CM et al. Association between human African trypanosomiasis and the IL6 gene in a Congolese population. Infect Genet Evol 2007; 7: 60-68.
67. Milet J, Nuel G, Watier L, Courtin D, Slaoui Y, Senghor P et al. Genome wide linkage study, using a 250K SNP map, of Plasmodium falciparum infection and mild malaria attack in a Senegalese population. PLoS ONE 2010; 5: e11616.
68. Le Port A, Cottrell G, Martin-Prevel Y, Migot-Nabias F, Cot M, Garcia A. First malaria infections in a cohort of infants in Benin: biological, environmental and genetic determinants. Description of the study site, population methods and preliminary results. BMJ Open 2012; 2: e000342.
69. Cervera I, Herraiz MA, Penaloza J, Barbolla ML, Jurado ML, Macedo J et al. Human leukocyte antigen-G allele polymorphisms have evolved following three different evolutionary lineages based on intron sequences. Hum Immunol 2010; 71: 1109-1115.
70. Lewontin RC. The interaction of selection and linkage. I. General considerations; heterotic models. Genetics 1964; 49: 49-67.
71. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005; 21: 263-265.
72. Excoffier L, Laval G, Schneider S. Arlequin (version 3.0): an integrated software package for population genetics data analysis. Evol Bioinform Online 2007; 1: 47-50.
73. Gabriel SB, Schaffner SF, Nguyen H, Moore JM, Roy J, Blumenstiel B et al. The structure of haplotype blocks in the human genome. Science 2002; 296: 2225-2229.
74. Stephens M, Smith NJ, Donnelly P. A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 2001; 68: 978-989.
75. Bandelt HJ, Forster P, Rohl A. Median-joining networks for inferring intraspecific phylogenies. Mol Biol Evol 1999; 16: 37-48.
76. Excoffier L, Smouse PE, Quattro JM. Analysis of molecular variance inferred from metric distances among DNA haplotypes: application to human mitochondrial DNA restriction data. Genetics 1992; 131: 479-491.
77. Stajich JE, Block D, Boulez K, Brenner SE, Chervitz SA, Dagdigian C et al. The Bioperl toolkit: Perl modules for the life sciences. Genome Res 2002; 12: 1611-1618.
78. Kelley JL, Madeoy J, Calhoun JC, Swanson W, Akey JM. Genomic signatures of positive selection in humans and the limits of outlier approaches. Genome Res 2006; 16: 980-989.
79. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 2007; 81: 559-575.
80. Beaumont MA, Nichols RA. Evaluating loci for use in the genetic analysis of population structure. Proc R Soc 1996; 263: 1619-1626.
81. Barreiro LB, Laval G, Quach H, Patin E, Quintana-Murci L. Natural selection has driven population differentiation in modern humans. Nat Genet 2008; 40: 340-345.
82. Tajima F. Statistical method for testing the neutral mutation hypothesis by DNA polymorphism. Genetics 1989; 123: 585-595.
83. Fu YX, Li WH. Statistical tests of neutrality of mutations. Genetics 1993; 133: 693-709.
84. Librado P, Rozas J. DnaSP v5: a software for comprehensive analysis of DNA polymorphism data. Bioinformatics 2009; 25: 1451-1452.
85. Woolfe A, Goode DK, Cooke J, Callaway H, Smith S, Snell P et al. CONDOR: a database resource of developmentally associated conserved non-coding elements. BMC. Dev Biol 2007; 7: 100.
86. Sabeti PC, Reich DE, Higgins JM, Levine HZ, Richter DJ, Schaffner SF et al. Detecting recent positive selection in the human genome from haplotype structure. Nature 2002; 419: 832-837.